Similarly, our work also indicated that Abx combined with the anti‐tumor drug DSF/Cu2+ had significantly inhibited the tumor growth in the melanoma‐bearing mice, accompanied by the reducing of inflammatory cytokines IL‐1β, IL‐6, and TNF‐α. This evidence concerns the gene IL6 and melanoma.